Further, CSF1R inhibitors (GW2580) reduce myeloid cells in the tumor microenvironment of gliomas and significantly decrease the expression of chemokine CXCL7, thus inhibiting tumor growth [69, 73]. Here, CSF1R is linked to neoplasm.